Lincoln Pharmaceuticals Ltd

NSE : LINCOLN17 Feb 2025
Pharmaceuticals
-1.55 (-0.28%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Ltd
Pharmaceuticals
NSE : LINCOLN17 Feb 2025
-1.55 (-0.28%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Lincoln Pharmaceuticals Ltd - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
-13.39%
Upper Circuit
Lower Circuit
P/E TTM
11.61
P/B Ratio
1.76
Traded Value(Cr)
0.01
EPS TTM
48.25
Book value
Dividend
0.32%

Invest in Lincoln Pharmaceuticals Ltd at ZERO Brokerage for 30 days

Price Performance

-24.98 %
1 Wk
-28.94 %
1 M
-8.89 %
3 M
-13.39 %
1 Y
-34.43 %
YTD

Traded Volume Movement

Technical Details

Support 3
518
Support 2
533
Support 1
547
Pivot Point :
562
Resistance 1
576
Resistance 2
591
Resistance 3
605

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Lincoln Pharmaceuticals Ltd
₹560.45(-1.55/-0.28%)
560.45-1.551,125.67-13.3911.611.76
Ipca Laboratories Ltd
₹1,482.95(+19.05/1.30%)
1,482.95+19.0537,139.7626.7853.165.50
Lupin Ltd
₹1,993.70(+23.80/1.21%)
1,993.70+23.8089,922.1922.2228.734.09
J B Chemicals & Pharmaceuticals Ltd
₹1,646.75(-22.55/-1.35%)
1,646.75-22.5525,975.36-0.4041.258.21
337.00+0.601,974.85-17.3120.301.19
Sanofi India Ltd
₹5,195.85(+46.10/0.90%)
5,195.85+46.1011,859.87-42.2328.2217.38

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 1122.37 crores. It has reported a sales of Rs. 146.55 crores and a net profit of Rs. 20.77 crores for the quarter ended December 2018. The company management includes Kishorbhai M Shah, Kishorbhai M Shah,Mahendra G Patel,Hasmukhbhai I Patel,Pirabhai R Suthar,Munjal Mahendrabhai Patel,Aashish R Patel,Meha Patel,Saurin J Parikh,Rajnikant G Patel,Anand Arvindbhai Patel,Trusha Shah (Lincoln Pharmaceuticals Ltd) among others.
Chairman
Kishorbhai M Shah
Registered office
Lincoln House B/H Satyam Compe,Science City Road Sola,Ahmedabad,Gujarat,380060
FAX :91-079-67778062
Background
Incorporation Year1995
Face Value₹10
Market Lot1

Latest News

Nifty 50 earnings growth remains sluggish for third straight quarter: M.O.

The earnings season for the October-December period marked the third consecutive quarter of low single-digit earnings growth, leaving analysts and investors wanting for more. Domestic brokerage Motilal Oswal noted that the slowdown in earnings growth has coincided with the ongoing market correction, as the Nifty 50 has recorded a 4 percent PAT growth in 9MFY25.
17 Feb 2025 | 10:27 AM

📢 Sensex plunges 627 points at the open; Nifty below 22,750

📈 Amid weak global cues, domestic benchmark indices started gap-down on 17 February, 2025.
📢 At 9:16 AM, the Sensex tanked 626.89 points or 0.83% at 75,312.32, and the Nifty plunged 195.70 points or 0.85% at 22,733.55.
📊 Oil India (⬇️4.00%), Aditya Birla FRL (⬇️3.07%) and PB Fintech (⬇️4.70%) appeared as the top losers on the Nifty 50 at the Open. A, B and C stocks are in focus today.
17 Feb 2025 | 09:30 AM

📢 Sensex plunges 627 points at the open; Nifty below 22,750

📈 Amid weak global cues, domestic benchmark indices started gap-down on 17 February, 2025.
📢 At 9:16 AM, the Sensex tanked 626.89 points or 0.83% at 75,312.32, and the Nifty plunged 195.70 points or 0.85% at 22,733.55.
📊 Oil India (⬇️4.00%), Aditya Birla FRL (⬇️3.07%) and PB Fintech (⬇️4.70%) appeared as the top losers on the Nifty 50 at the Open. A, B and C stocks are in focus today.
17 Feb 2025 | 09:30 AM

Lesha Ind Standalone December 2024 Net Sales at Rs 0.45 crore

Reported Standalone quarterly numbers for Lesha Industries are: Net Sales at Rs 0.45 crore in December 2024 down 79.3% from Rs. 2.19 crore in December 2023. Quarterly Net Profit at Rs. 0.05 crore in December 2024 down 83.79% from Rs. 0.34 crore in December 2023. EBITDA stands at Rs. 0.07 crore in December 2024 down 80% from Rs. 0.35 crore in December 2023.
17 Feb 2025 | 12:02 PM

TCS to roll out 4-8% salary hikes in March; payouts to begin in April

Tata Consultancy Services (TCS) will implement 4-8% annual salary hikes in March, with payouts starting in April, as the industry aligns with slower growth trends, a departure from the double-digit hikes seen during the COVID-19 period. TCS reported an 11.95% year-on-year rise in consolidated net profit, reaching Rs 12,380 crore for the December quarter.
17 Feb 2025 | 12:00 PM

How to buy Lincoln Pharmaceuticals Ltd shares on nse?

To buy Lincoln Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Lincoln Pharmaceuticals Ltd share price today?

The Lincoln Pharmaceuticals Ltd shares price on nse is Rs.560.45 today.

What is the market cap of Lincoln Pharmaceuticals Ltd shares on NSE ?

The company has a market capitalization of Rs.1125.67Cr

What is the PE & PB ratio of Lincoln Pharmaceuticals Ltd shares ?

PE is 11.61 and PB is 1.76

What is the 52 Week High and Low of Lincoln Pharmaceuticals Ltd shares?

Lincoln Pharmaceuticals Ltd stock price high: Rs.979.5 Lincoln Pharmaceuticals Ltd stock price low: Rs.534.8
Click here to see your activities